RxDoctor Payments Data

John Booker

Family Medicine · Visalia, CANPI 1790769768

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $892 and has fallen 97.7% since, to $21 in 2023.

$1,771in general payments, 2019–2025

Across 96 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$328
  • Amgen$290
  • Merck$161
  • Novo Nordisk$154
  • Lilly USA, LLC$137
  • Boehringer Ingelheim$136
  • plus $563 from 16 others

What the payments were for

  • Food & beverage$1,764100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,771 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Visalia

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →